World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
15450
World Ranking
3306
National Ranking
1537

Phyllis J. Kanki publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Phyllis J. Kanki sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 284 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Phyllis J. Kanki D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Phyllis J. Kanki sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2008 - Member of the National Academy of Medicine (NAM)

Overview

Phyllis J. Kanki is affiliated with Harvard University in the United States and has contributed extensively to the field of medicine, with a particular focus on infectious diseases. Their research spans several subfields including infectious diseases, public health, environmental and occupational health, virology, epidemiology, and modeling and simulation.

The scientist's research topics cover a range of areas related to viral infections, with a notable emphasis on HIV/AIDS and SARS-CoV-2. Key topics include HIV/AIDS research and interventions, SARS-CoV-2 and COVID-19 research, HIV research and treatment, mosquito-borne diseases and control, viral infections and vectors, HIV/AIDS drug development and treatment, and SARS-CoV-2 detection and testing.

Phyllis J. Kanki has published in several venues, often contributing to journals that focus on infectious diseases and public health. Frequent publication venues include bioRxiv (Cold Spring Harbor Laboratory), PLoS ONE, Emerging Microbes & Infections, Clinical Infectious Diseases, and Pediatric Cardiology.

Recent notable papers include:

  • "Reported Barriers to Healthcare Access and Service Disruptions Caused by COVID-19 in Burkina Faso, Ethiopia, and Nigeria: A Telephone Survey," 2021, American Journal of Tropical Medicine and Hygiene
  • "Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture," 2022, Journal of Clinical Microbiology
  • "Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort," 2022, Clinical Microbiology and Infection
  • "Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa," 2022, AIDS and Behavior
  • "Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria," 2020, PLoS ONE

Collaborative work has involved frequent co-authors such as Charlotte A. Chang, Donald J. Hamel, Beth Chaplin, Prosper Okonkwo, and Atiene S. Sagay, with whom this scientist has published multiple papers.

Phyllis J. Kanki is a member of the National Academy of Medicine, an honor received in 2008.

Best Publications

  • Isolation of T-cell tropic HTLV-III-like retrovirus from macaques

    Daniel;NL Letvin;NW King;M Kannagi

  • Reduced rate of disease development after HIV-2 infection as compared to HIV-1

    Richard Marlink;Phyllis Kanki;Ibou Thior;Karin Travers

  • SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA

    F. Barin;F. Denis;J.S. Allan;S. M'Boup

  • Slower heterosexual spread of HIV-2 than HIV-1.

    P.J. Kanki;K.U. Travers;R.G. Marlink;M.E. Essex

  • Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression

    Phyllis J. Kanki;Donald J. Hamel;Jean-Louis Sankalé;Chung-cheng Hsieh

  • New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

    P J Kanki;F Barin;S M'Boup;J S Allan

  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

    Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  • Serologic identification and characterization of a macaque T-lymphotropic rétrovirus closely related to HTLV-III

    P. J. Kanki;M. F. McLane;N. W. King;N. L. Letvin

  • Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV-1 and HIV-2

    Stephen J. Popper;Abdoulaye Dieng Sarr;Karin U. Travers;Aissatou Guèye-Ndiaye

  • Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.

    A.J. Nahmias;J. Weiss;X. Yao;F. Lee

  • Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal

    Peter B. Gilbert;Ian W. McKeague;Geoffrey Eisen;Christopher Mullins

  • Isolation of T-Lymphotropic Retrovirus Related to HTLV-III/LAV from Wild-Caught African Green Monkeys

    P. J. Kanki;J. Alroy;M. Essex

  • A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

    Jonathan S. Allan;John E. Coligan;Tun-Hou Lee;Mary Frances McLane

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  • Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo

    Stephen J. Popper;Abdoulaye Dieng Sarr;Aïssatou Guèye-Ndiaye;Souleymane Mboup

  • Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

    H Cao;P Kanki;J L Sankalé;A Dieng-Sarr

  • Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients

    Jesse A. Otegbayo;Babafemi O Taiwo;Titilola S Akingbola;Georgina N. Odaibo

  • High Levels of Tumor Necrosis Factor—α and Interleukin-1β in Bacterial Vaginosis May Increase Susceptibility to Human Immunodeficiency Virus

    Katharine Sturm-Ramirez;Aïssatou Gaye-Diallo;Geoffrey Eisen;Souleymane Mboup

  • Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa

    Phyllis J. Kanki;Souleymane M'Boup;Dominique Ricard;Francis Barin

  • Lymphoma in macaques: association with virus of human T lymphotrophic family

    T. Homma;P. J. Kanki;N. W. King;R. D. Hunt

Frequent Co-Authors

Souleymane Mboup
Souleymane Mboup Institute of Health Research, Epidemiological Surveillance and Training
Myron Essex
Myron Essex Harvard University
Robert L. Murphy
Robert L. Murphy Northwestern University
Richard Marlink
Richard Marlink Rutgers, The State University of New Jersey
François Denis
François Denis Hôpital Universitaire Dupuytren
Eric J. Tchetgen Tchetgen
Eric J. Tchetgen Tchetgen University of Pennsylvania
Tobias F. Rinke de Wit
Tobias F. Rinke de Wit University of Amsterdam
Tulio de Oliveira
Tulio de Oliveira University of KwaZulu-Natal
Martine Peeters
Martine Peeters Institut de Recherche pour le Développement

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees can open diverse career pathways in healthcare and research. Many students consider nursing-focused advanced degrees, which offer practical clinical skills and strong job prospects. For instance, exploring the easiest nurse practitioner degree programs can help students find flexible online options that suit different learning styles and schedules.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are another valuable route, especially for those keen on mental health immunology intersections. The best online pmhnp programs frequently offer strong clinical placement opportunities, which are critical for hands-on experience and career readiness.

Cost is a significant factor when choosing a program. Prospective students should consider cheapest pmhnp programs to access quality education without excessive financial burden. This can be especially relevant for those balancing work or family commitments.

Finally, understanding potential earnings can guide career decisions. Reviewing the dnp salary by specialty offers insights into income expectations across states and specialties, helping graduates target the most rewarding career paths post-degree.

Best Scientists Citing Phyllis J. Kanki

Trending Scientists

Recently Published Articles